Stacie M. Jones
Professor
Also affiliated: University of North Carolina at Chapel Hill (2017–2020); Scripps Research Institute (2004); Atrium Health Wake Forest Baptist (1996); National Institutes of Health (2024); Arkansas Children's Hospital (1991–2026); Children's Hospital of Philadelphia (1996); Johns Hopkins University (1995–2024); University of California, Los Angeles (2023); The University of Queensland (2023); University of California, San Francisco (2023); Guy's and St Thomas' NHS Foundation Trust (2022); University of Washington (2006); University of Arkansas Medical Center (2006–2026); University of Arkansas System (2014); Johns Hopkins Medicine (1996–2024); National Jewish Health (2005); University of California San Diego (2023); University of Chicago (1996); Children's Hospital Colorado (2023); National Institute of Allergy and Infectious Diseases (2017–2024); Johns Hopkins Hospital (2006–2024); Arkansas Children's Research Institute (2004–2026); University of Colorado Anschutz (2023); American College of Emergency Physicians (2015); Procter & Gamble (United States) (1991); University of Pennsylvania (2006); Stanford University (2023); Icahn School of Medicine at Mount Sinai (2010–2024)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Stacie M. Jones, a professor at the University of Arkansas for Medical Sciences, has a scholarly h-index of 69 with over 443 publications and 21,690 citations. Her research focuses on the diagnosis and management of food allergies, particularly in children. Jones has been involved in developing and updating national guidelines for food allergy diagnosis and management, including reports from the National Institute of Allergy and Infectious Diseases (NIAID).
Her work has investigated the efficacy of oral immunotherapy as a treatment for food allergies, specifically peanut and egg allergies. These studies examine clinical desensitization and the modulation of allergic responses. Jones has also published on related topics such as X-linked agammaglobulinemia, highlighting her broad interest in immunologic conditions. She maintains an active research group and collaborates with colleagues at the University of Arkansas for Medical Sciences, including Amy S. Scurlock, Robbie Pesek, Dieu Doan, and Samer Abdelkader.
Metrics
- h-index: 68
- Publications: 454
- Citations: 22,773
Positions
-
Professor 1994–presentUniversity of Arkansas for Medical Sciences Pediatrics ORCID
Selected Publications
-
Treatment of Multifood Allergy With Omalizumab or Multiallergen Oral Immunotherapy (2026)
-
Implementation of early peanut introduction among providers in a southern US state (2026)
-
Dupilumab Failures in Pediatric and Adolescent Eosinophilic Esophagitis: A Retrospective Cohort Study (2026)
-
Management of Gastrointestinal Symptoms During Oral Immunotherapy: Guidance from OUtMATCH Investigators (2026)
-
Genetic Determinants of Peanut‐Specific <scp>IgG4</scp> Levels in the Context of Sustained Oral Peanut Exposure in the <scp>LEAP</scp> Study (2026)
-
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies (2025)
-
Introduction of allergenic foods after treatment with omalizumab (2025)
-
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE (2025)
-
Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis (2025)
-
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy (2024)
-
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study (2024)
-
Impact of Atopic Status on Clinical Presentation and Treatment Response in Pediatric Patients With Eosinophilic Esophagitis (2024)
-
Enhanced Gut Microbiome Capacity for Amino Acid Metabolism is associated with Peanut Oral Immunotherapy Failure (2024)
-
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow’s Milk Allergy (2024)
-
Long-Term Follow-up after IMPACT Peanut Oral Immunotherapy Clinical Trial (2024)
Collaboration Network
Top Collaborators
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
- Clinical efficacy and immune regulation with peanut oral immunotherapy
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- ICON: Food allergy
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
Showing 5 of 75 shared publications
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- ICON: Food allergy
- Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
- The natural history of milk allergy in an observational cohort
- Early-life gut microbiome composition and milk allergy resolution
Showing 5 of 54 shared publications
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- ICON: Food allergy
- Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
- The natural history of milk allergy in an observational cohort
Showing 5 of 54 shared publications
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- ICON: Food allergy
- The natural history of milk allergy in an observational cohort
- Early-life gut microbiome composition and milk allergy resolution
Showing 5 of 47 shared publications
- Clinical efficacy and immune regulation with peanut oral immunotherapy
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Egg oral immunotherapy in nonanaphylactic children with egg allergy
Showing 5 of 38 shared publications
- Clinical efficacy and immune regulation with peanut oral immunotherapy
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- The natural history of milk allergy in an observational cohort
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
Showing 5 of 37 shared publications
- Early-life gut microbiome composition and milk allergy resolution
- Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
- A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
- Early‐life gut microbiome and egg allergy
- Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy
Showing 5 of 30 shared publications
- Clinical efficacy and immune regulation with peanut oral immunotherapy
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Allergic Reactions to Foods in Preschool-Aged Children in a Prospective Observational Food Allergy Study
- Adverse reactions during peanut oral immunotherapy home dosing
Showing 5 of 28 shared publications
- Early-life gut microbiome composition and milk allergy resolution
- Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
- Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
- The natural history of egg allergy in an observational cohort
- Early‐life gut microbiome and egg allergy
Showing 5 of 21 shared publications
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
- Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
- Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial
Showing 5 of 21 shared publications
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
- Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
- Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy
- Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
- Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
Showing 5 of 18 shared publications
- Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
- Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
- Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
- Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy
- Sublingual versus oral immunotherapy for peanut-allergic children: A retrospective comparison
Showing 5 of 18 shared publications
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- The natural history of milk allergy in an observational cohort
- Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
- Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial
- Allergic Reactions to Foods in Preschool-Aged Children in a Prospective Observational Food Allergy Study
Showing 5 of 17 shared publications
- Clinical efficacy and immune regulation with peanut oral immunotherapy
- A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
- Egg oral immunotherapy in nonanaphylactic children with egg allergy
- Safety of a peanut oral immunotherapy protocol in children with peanut allergy
Showing 5 of 16 shared publications
- Clinical efficacy and immune regulation with peanut oral immunotherapy
- Oral Immunotherapy for Treatment of Egg Allergy in Children
- Evidence of pathway‐specific basophil anergy induced by peanut oral immunotherapy in peanut‐allergic children
- Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy
- Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
Showing 5 of 16 shared publications
Similar Researchers
Based on overlapping research topics